Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorized
  2. c-icon icon-chevron-right
April 23, 2020

Imperial College London gets UK funding for Covid-19 vaccine

Imperial College London has secured £22.5m from the UK Government to accelerate the development of a potential Covid-19 vaccine.

Since February, researchers at Imperial have been studying a self-amplifying RNA vaccine candidate in animals.

The government funding will be used to support Phase II trials and to make preparations for a large Phase III trial.

Read the full article here

Related Companies

Content from our partners
The importance of reference products in biosimilar trials, and how to source them
Africa’s last mile: Building viable vaccine supply chains
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU